Fusion Partner and ER-Retention Signal Are Associated with Distinct Host Proteomic and Metabolic Responses During Interleukin-15 Production in Nicotiana benthamiana
The results demonstrate that fusion partner and SP/KD targeting strategy jointly shape the host response to recombinant IL-15 expression and should therefore be evaluated together during construct design for plant molecular farming.
Abstract
Plant molecular farming has emerged as a promising platform to produce recombinant biopharmaceuticals. The expression of foreign proteins changes the host proteome and metabolome, and these changes might have an effect on the accumulation of recombinant proteins. In this study, we investigated how fusion partners and ER-retention strategies influence host responses during transient production of recombinant human interleukin-15 (IL-15) in Nicotiana benthamiana. Four IL-15 constructs carrying either an 8 × His tag or an IgG1 Fc fusion, with or without an N-terminal signal peptide and C-terminal SEKDEL motif (KD), were compared at 4 days post-infiltration. Western blot analysis detected IL-15 only in the Fc-fusion constructs. Plants expressing IL15-Fc accumulated more antioxidant enzymes and phenylpropanoid-derived phenolics. Expression of IL15-Fc with the SP/KD construct showed increased abundance of proteins involved in protein folding and translation, together with reduced representation of secondary metabolic pathways. Overall, the results demonstrate that fusion partner and SP/KD targeting strategy jointly shape the host response to recombinant IL-15 expression and should therefore be evaluated together during construct design for plant molecular farming.
It is demonstrated that maximizing recombinant protein production requires optimization of both yield and structural quality and establish complementary strategies for improving secreted protein expression in Pichia.
The ascomycete fungal pathogen Blumeria hordei (Bh) is predicted to secrete over 530 effector proteins to infect barley and cause powdery mildew disease, yet their individual and collective functions are largely unexplored. We used yeast two-hybrid next-generation interaction screening (Y2H-NGIS) to probe the host targ...
J. M. Elmore, Valeria Velásquez-Zapata, Gregory Fuerst et al.· bioRxiv· 0 citations
Production of commercial antibodies commonly relies on mammalian expression platforms; however, these are associated with high production costs and technical challenges during large-scale cultivation. In this study, we aimed to develop an Escherichia coli-based platform for the production of an anti-PD-L1 single-chain...
Sarinthip Khamthiang, Chonlaphon Juntama, A. Panya et al.· Life· 0 citations
The research aimed to develop a production platform for the OKT3 (Muromonab-CD3) monoclonal antibody, which specifically targets the CD3 receptor on T-lymphocytes, using Nicotiana benthamiana and the geminiviral transient expression system (pBYR2e). The heavy and light chain genes of OKT3 were codon-optimized for the h...
The interleukin-1 receptor antagonist (IL-1Ra) is a key anti-inflammatory cytokine that inhibits interleukin-1 signaling by competitively binding to IL-1 receptors. However, recombinant IL-1Ra, currently produced in Escherichia coli, exhibits limited pharmacokinetics and requires frequent administration due to its sh...
Anith Kumar Rajendran, Vaishnavi Ashokkumar, T. Krishnaraj et al.· ACS Synthetic Biology· 0 citations
Sensing of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors at the cell surface initiates the first layer of host immunity against invading microbial pathogens. In plants, the immune receptor Flagellin Sensing 2 (FLS2) perceives bacterial flagellin to trigger downstream signaling that cul...
Chao-Feng Wang, Yi Zhang, Bang-Jun Zhou et al.· New Phytologist· 0 citations
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.